if you take a look at MYL, epipen won't affect MYL's guidance after 2017. MYL CEO's father is with H. So it is a show, not a policy.
if you take a look at MYL, epipen won't affect MYL's guidance after 2017. MYL CEO's father is with H. So it is a show, not a policy.